Teva Files Suit Against India’s Lupin to Keep Oral Contraceptive Monopoly

Teva Women’s Health has filed suit in the US District Court for New Jersey, claiming that Lupin had filed an abbreviated new drug application (ANDA) with the US Food and Drug Administration (FDA) which infringes the patents of Seasonale, an oral contraceptive owned by Teva since they bought out Barr last year for $7.6 billion. The purpose of the suit is to prevent sales of the infringing drug.

Seasonale limits the number of menstrual periods women have in a year from 12 (monthly) to 4 (seasonally). the drug has annual sales in the US, exceeding $120 million.



Categories: Intellectual Property, News, pharmaceuticals, pharmaceuticals and Biotechnology, Teva

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: